⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21751742 | 1.00 | — | — | |
| SCHEMBL21751635 | 0.81 | MAPT (0.38) | — | |
| SCHEMBL23908110 | 0.81 | CYP2C9 (0.33) | — | |
| SCHEMBL21751539 | 0.79 | SLC6A2 (0.32) | — | |
| SCHEMBL23908158 | 0.79 | RIPK1 (0.30) | — | |
| SCHEMBL21751713 | 0.78 | CDK8 (0.33) | — | |
| SCHEMBL21751728 | 0.78 | — | — | |
| SCHEMBL21751681 | 0.75 | CDK8 (0.36) | — | |
| SCHEMBL21751683 | 0.74 | HSP90AA1 (0.30) | — | |
| SCHEMBL23908102 | 0.70 | FLT3 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4110298-A1 | HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2 INHIBITOR | Guangzhou Lupeng Pharmaceutical Company Ltd. (CN) | 2023-01-04 | — | — | EP | disclosed |
| WO-2020041406-A1 | BCL-2 INHIBITORS | NEWAVE PHARMACEUTICAL INC. (US) | 2020-02-27 | — | — | WO | disclosed |